Acquisition of hepatitis C virus in hemodialysis patients: A prospective study by branched DNA signal amplification assay

American Journal of Kidney Diseases

Volumn 31, Issue 4, 1998, Pages 647-654

  Fabrizi, Fabrizio ^a   Martin, Paul ^a   Dixit, Vivek ^a   Brezina, Maria ^a   Cole, Mary J ^a   Gerosa, Silvia ^a   Mousa, Mariam ^a   Gitnick, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ALT; bDNA assay; HCV incidence; HCV viremia; HD

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; FEMALE; GENE AMPLIFICATION; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INCIDENCE; KIDNEY FAILURE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; VIREMIA; VIRUS DETECTION;

EID: 0031916989     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9531181     Document Type: Article

References (54)

1. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV: Prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 112:958-960, 1990
2. Jeffers LJ, Perez GO, de Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy KR, Jimenez M, Bourgoignie JJ, Vaamonde CA, Duncan R, Houghton M, Choo GL, Kuo G: Hepatitis C virus infection in two urban haemodialysis units. Kidney Int 38:320-322, 1990
3. Oguchi H, Miyasaka M, Yokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T, Natanabe H, Yoshizawa S, Sato K, Terashima M, Yoshie T, Oguchi S, Tanaka E, Kiyosawa K, Furuta S: Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 38:36-43, 1992
4. Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K: Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 8:744-747, 1993
5. Kuhns M, De Medina M, McNamara A, Alleman S, Krenc C, Jeffers L, Reddy R, Silva M, Ortiz-Interian C, Schiff E, Perez G: Detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol 4:1491-1497, 1994
6. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A: High prevalence of antibodies to hepatitis C virus in hemodialysis patients using a second-generation assay. Nephron 61:350-351, 1992
7. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C: Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 44:1097-1100, 1993
8. Chauveau P, Couroucè AM, LeMarec N, Naret C, Poignet JL, Girault A, Ramdame M, Delons S: Antibodies to hepatitis C virus by second-generation test in hemodialyzed patients. Kidney Int 41:S149-S152, 1993
9. Fabrizi F, Bacchini G, Pontoriero G, Guarnori I, Erba GF, Locatelli F: Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: A study with second-generation assays. Nephrol Dial Transplant 8:744-747, 1993
10. Hardy NM, Sandroni S, Danielson S, Wilson WJ: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 38:44-48, 1992
11. Muller G, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, Machado IV: Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 41:1055-1058, 1992
12. Niu MT, Alter MJ, Kristensen C, Margolis H: Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 19:345-352, 1992
13. Gilli P, Moretti M, Soffritti S, Marchi N, Malacarne F, Bedani PL, De Paoli Vitali E, Fiocchi O, Menini C: Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 13:737-741, 1990
14. Marchesi D, Arici C, Poletti E, Mingardi G, Minola E, Mecca G: Outbreak of non-A, non-B hepatitis in centre haemodialysis patients: A retrospective analysis. Nephrol Dial Transplant 3:795-799, 1988
15. Gitnick G, Weiss S, Overby LR, Ling CM, Chairez R, Parsa K: Non-A, non-B hepatitis: A prospective study of a hemodialysis outbreak with evaluation of a serological marker in patients and staff. Hepatology 3:625-630, 1983
16. Tokars JI, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1993. ASAIO J 42:219-229, 1996
17. Medin C, Allander T, Roll M, Jacobson SH, Grillner L: Seroconversion to hepatitis C virus in dialysis patients: A retrospective and prospective study. Nephron 65:40-45, 1993
18. Jadoul M, Cornu C, van Ypersele de Strihou, UCL Collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44:1322-1326, 1993
19. Niu M, Coleman P, Alter MJ: Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 22:568-573, 1993
20. Lin DY, Lin HH, Huang CC, Liaw YF: High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan. Am J Kidney Dis 21:288-291, 1993
21. Simon N, Couroucè AM, Lemarrec N, Trepo C, Ducamp S: A twelve-year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 46:504-511, 1994
22. + patients' isolation on HCV incidence in a dialysis unit. Nephrol Dial Transplant 7:1069-1070, 1992
23. Teruel JL, Pascual J, Liano F, Ortuno J: Importance of nosocomial transmission of hepatitis C virus infection in dialysis units. Clin Nephrol 38:232-233, 1992
24. Robles NR, Gomez Ainsua C, Cruz A: Lack of transmission of hepatitis C virus (HCV) in hemodialysis patients: Study of risk factors. Nephrol Dial Transplant 7:981-982, 1992
25. Dentico P, Buongiorno R, Volpe A: Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: Study of risk factors. Clin Nephrol 38:50-54, 1992
26. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Crepaldi M, Pagano A, Locatelli F: Incidence of seroconversion for hepatitis C virus in chronic hemodialysis patients: A prospective study. Nephrol Dial Transplant 9:1611-1615, 1994
27. Fernandez JL, del Pino N, Lef L, Valtuille R, Berridi J, Rendo P, Viola L: Serum hepatitis C virus RNA in anti-HCV negative hemodialysis patients. Dial Transplant 25:14-18, 1996
28. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell FH, Miller RH: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 168:1343-1348, 1993
29. Chan TM, Lok ASF, Cheng IKPC, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:135-139, 1993
30. Rosen HR, Friedman LS, Martin P: Hepatitis C in renal dialysis and transplant patients. Viral Hep 2:97-110, 1996
31. Urdea M: Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV and HIV. Clin Chem 39:725-726, 1993
32. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shih JW, Neuwald PD: Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Vir Hepatitis 2:121-132, 1995
33. Tong MJ, Hwang SJ, Lafkowitz M, Lee SD, Co RL, Conrad A, Schmid P, Lo KJ: Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J Gastroenterol Hepatol 9:587-591, 1994
34. Martin P, Brezina M, Dixit V, DiNello R, Quan S, Polito A, Gitnick G: Acquisition of hepatitis C virus by hemodialysis patients. Hepatology 18:93A, 1993 (abstr)
35. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH: Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 69:459-465, 1995
36. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y: Hypoamino-transferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology 109:1295-1300, 1995
37. Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Pagano A, Locatelli F: Influence of serum HCV RNA upon aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 12:1394-1398, 1997
38. Favero MS, Alter MJ, Bland LA: Dialysis-associated infections and their control, in Bennett JL, Brechman P (eds): Hospital Infections (ed 3). Boston, MA, Little, Brown, 1992, pp 375-403
39. Besso L, Rovere A, Peano G, Menardi G, Fenoglio LM, Fenoglio S, Ghezzi PM: Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis units. Nephron 61:304-306, 1992
40. Sampietro M, Badalamenti S, Salvadori S, Corbetta N, Graziani G, Como G, Fiorelli G, Ponticelli C: High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 47:911-917, 1995
41. Corcoran GD, Brink NS, Millar CGM, Garson JA, Waite J, Deaville R, Thompson FD, Tedder RS: Hepatitis transmission in hemodialysis patients: A clinical and virological study. J Infect 28:279-285, 1994
42. Lombardi M, Cerrai T, Dattolo P, Pizzarelli F, Maggiore Q: Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 10:578-579, 1995
43. Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL: Prevention of hepatitis C virus in dialysis units. Nephron 70:301-306, 1995
44. MMWR. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in healthcare settings. JAMA 260:462-465, 1988
45. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724, 1993
46. Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J: Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337-1341, 1994
47. Chan TM, Lok AS, Cheng IK, Chan RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104:862-868, 1993
48. Lau J, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan S, DiNello R, Polito A, Scornick JC: Hepatitis C virus infection in kidney transplant recipients. Hepatology 18:1027-1031, 1993
49. Gretch D, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L: Assessment of hepatitis C viremia using amplification technologies: Correlations and clinical implications. Ann Intern Med 123:321-329, 1995
50. Garcia-Valdecasas J, Bernal MC, Cerezo S, Garcia F, Pereira BJG: Strategies to reduce the transmission of HCV infection in hemodialysis units. J Am Soc Nephrol 4:59P, 1993
51. Chiaramonte S, Tagger A, Ribeiro ML, Grossi A, Milan M, La Greca G: Prevention of viral hepatitis in dialysis units: Isolation and technical management of dialysis. Nephron 61:287-289, 1992
52. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N: Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140, 1992
53. Lai ME, Mazzoleni AP, Argiolu F, Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P: Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388-390, 1994
54. Widell A, Mansson S, Parsson NH, Thysell H, Hermodsson S, Blohme I: Hepatitis C virus superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 60:642-647, 1995